You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
AstraZeneca
McKinsey
Merck
Medtronic

Last Updated: July 10, 2020

DrugPatentWatch Database Preview

Patent: 9,976,171

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,976,171
Title:Method for dissolution testing of solid compositions containing digestive enzymes
Abstract: The invention is directed to a process for measuring the amount of digestive enzymes released from a solid composition in a dissolution medium by fluorescence spectroscopy. The invention is also directed to a combined method for measuring both the dissolution and gastroresistance of a solid compositions comprising pancrelipase.
Inventor(s): Latino; Massimo (Cinisello Balsamo, IT), Ghidorsi; Luigi (Milan, IT), Ortenzi; Giovanni (Monza, IT)
Assignee: ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED (IE)
Application Number:14/237,180
Patent Claims:see list of patent claims

Details for Patent 9,976,171

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Digestive Care, Inc. PERTZYE pancrelipase CAPSULE, DELAYED RELEASE 022175 1 2012-05-17   Start Trial ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED (IE) 2040-03-30 search
Digestive Care Inc PERTZYE pancrelipase (amylase;lipase;protease) CAPSULE, DELAYED RELEASE;ORAL 022175 004 2014-01-23   Start Trial ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED (IE) 2040-03-30 RX search
Digestive Care Inc PERTZYE pancrelipase (amylase;lipase;protease) CAPSULE, DELAYED RELEASE;ORAL 022175 003 2014-01-23   Start Trial ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED (IE) 2040-03-30 RX search
Digestive Care Inc PERTZYE pancrelipase (amylase;lipase;protease) CAPSULE, DELAYED RELEASE;ORAL 022175 002 2014-01-23   Start Trial ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED (IE) 2040-03-30 RX search
Digestive Care Inc PERTZYE pancrelipase (amylase;lipase;protease) CAPSULE, DELAYED RELEASE;ORAL 022175 001 2014-01-23   Start Trial ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED (IE) 2040-03-30 RX search
Abbvie Inc. CREON pancrelipase CAPSULE, DELAYED RELEASE PELLETS 020725 1 2013-03-14   Start Trial ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED (IE) 2040-03-30 search
Abbvie CREON pancrelipase (amylase;lipase;protease) CAPSULE, DELAYED RELEASE;ORAL 020725 005 2009-04-30   Start Trial ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED (IE) 2040-03-30 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 9,976,171

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Merck
Medtronic
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.